22nd Century Group Inc/ US90137F3010 /
2024-11-08 9:59:34 PM | Chg. 0.00 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.12USD | +2.24% | 12,974 Turnover: 1,532.46 |
-Bid Size: - | -Ask Size: - | 0.13 | 0.11 |
GlobeNewswire
02-06
Presenting on the Emerging Growth Conference 67 Day 1 on February 7 Register Now
GlobeNewswire
2023-11-08
22nd Century Group Continues VLN® Expansion, Now Retailing in More Than 5,100 Stores
GlobeNewswire
2023-11-07
22nd Century Group (XXII) Expands Reduced Nicotine Content Tobacco IP with Latest Technology License
GlobeNewswire
2023-10-26
22nd Century Group (XXII) Supports FDA Policy Advancements, Proposed Menthol Ban Now at OMB
GlobeNewswire
2023-09-12
22nd Century Group (XXII) Adds 1,200 Drug Store Locations Selling VLN® in Five States
GlobeNewswire
2023-09-05
22nd Century Group Initiates Strategic Alternatives Process for Its Tobacco Assets
GlobeNewswire
2023-09-05
Presenting on the Emerging Growth Conference on September 6 and 7 Register Now
GlobeNewswire
2022-03-28
FDA Authorized Reduced-Nicotine Cigarette from 22nd Century Group (Nasdaq: XXII) That ‘Helps You Smo...
GlobeNewswire
2022-03-09
22nd Century Group (Nasdaq: XXII) to Host Investor Meetings at Roth Capital Conference March 14-15
GlobeNewswire
2022-02-28
22nd Century Group Announces South Korea as First VLN® International Market
GlobeNewswire
2022-02-25
22nd Century Group Welcomes Dr. Califf as FDA Commissioner, Urges Action on Menthol and Nicotine in ...
GlobeNewswire
2022-02-03
22nd Century Group to Announce Fourth Quarter and Full Year 2021 Results on March 1, 2022
GlobeNewswire
2022-01-26
22nd Century Group Announces First Production of VLN® Cigarettes for Retail Sale